-
Xortx Therapeutics to assess XRx-101 for Covid-19 treatment
.pharmaceutical-technology
March 18, 2020
Xortx Therapeutics is set to explore XRx-101, a formulation of Oxypurinol, as a potential treatment for acute kidney and lung injury associated with Covid-19.
-
More Studies Link Vaping to Asthma, COPD
drugs
January 15, 2020
Lung illnesses and deaths from vaping have been grabbing headlines for months, and now two new studies offer fresh evidence pointing to long-term respiratory concerns.
-
Incidence of Nontuberculous Mycobacteria Lung Disease Rising
drugs
December 26, 2019
The incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in the United States, according to a study published online in the Annals of the American Thoracic Society.
-
Vitamin E Acetate ID'd in Lungs of Most Vaping Illness Patients
drugs
December 25, 2019
Vitamin E acetate was identified in almost all patients with electronic cigarette, or vaping, product use-associated lung injury (EVALI), and there has been a decrease in EVALI cases since a peak in September 2019 ...
-
Transplant Outcomes Similar With Lungs From 'Increased-Risk' Donors
drugs
December 25, 2019
Using lungs for transplant from donors who are considered at high risk for certain infectious diseases has similar one-year outcomes for recipients compared with using lungs from standard-risk donors ...
-
Researchers use three-drug combination to treat lung cancer
pharmaceutical-technology
September 26, 2019
A study by the Francis Crick Institute and The Institute of Cancer Research, London has tested the combination of a G12C KRAS inhibitor with mTOR and IGF1R inhibitors for the treatment of lung cancer.
-
Bayer invests in joint research lab for chronic lung diseases
pharmaceutical-technology
September 26, 2019
Bayer has committed more than $30m over the next five years to support research projects on therapies for chronic lung diseases at a joint lab in the US.
-
Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases
worldpharmanews
September 25, 2019
Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) announced the launch of a joint lab to research new drug candidates ...
-
CDC: Cases of Vaping-Linked Lung Illness Rise to 530 Across 38 States
drugs
September 20, 2019
The number of confirmed or suspected severe lung illnesses linked to vaping has risen to 530 cases across 38 states and the Virgin Islands, U.S. health officials reported Thursday.
-
CDC Revises Number of Vaping-Linked Lung Illnesses to 380
drugs
September 16, 2019
U.S. health officials have revised downward the number of cases of severe lung injury linked to vaping, from more than 450 cases cited last week to the total of 380 cases announced late Thursday.